Delivery Order SPE2DB20D3103-SPE2DB25FQ1K1
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,687.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Entresto 49 mg-51 mg, a pharmaceutical product used in heart failure treatment. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive, non-set-aside delivery order executed under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $28,354.52 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at $43,457.38 to AmerisourceBergen Drug Corp for Entresto 49 mg-51 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and represents pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,655.50 to AmerisourceBergen Drug Corp for 180 tablets of Entresto 24 mg-26 mg, a pharmaceutical product used in heart failure treatment. This competitive, non-set-aside delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing under a...
- The Defense Logistics Agency awarded a $24,605.54 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract type. This delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $6,847.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Entresto 97 mg-103 mg on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $7,035.35 to AmerisourceBergen Drug Corp for 180 tablets of Entresto 49 mg-51 mg, a combination pharmaceutical used in heart failure treatment. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location....
- The Defense Logistics Agency awarded a $4,960.20 delivery order to AmerisourceBergen Drug Corp for supply of Entresto 24 mg-26 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $13,183.45 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive delivery order utilizing the company's existing pharmaceutical supply agreement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in...